Literature DB >> 1712477

Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide.

W C Van Voorhis1, L Schlekewy, H L Trong.   

Abstract

Antigenic mimicry by Trypanosoma cruzi antigens that share epitopes with mammalian tissues may drive autoreactive B- or T-cell clones to expand and cause autoimmune pathogenesis. We have been studying one of these antigens, F1-160, a 160-kDa protein on the surface of T. cruzi that antigenically mimics a 48-kDa protein found in mammalian axonal and myenteric plexus cells. The F1-160 antigen has been characterized by cloning and expression of T. cruzi DNA encoding F1-160 in Escherichia coli. Recombinant peptides from various regions of the F1-160 gene were expressed and used to compete with affinity-purified polyclonal anti-F1-160 antibodies binding to nerve. Recombinant 48-amino acid peptide (48X) derived from expression of base pairs 611-761 of the DNA sequence completely inhibited anti-F1-160 binding to nerve. Recombinant peptides expressed from DNA lacking this region did not inhibit anti-F1-160 binding to nerve. Three peptides were synthesized to encompass the 48X peptide, a 12-amino acid peptide and two 18-amino acid peptides. The 12-amino acid peptide TPQRKTTEDRPQ (12X), corresponding to bases 615-651, completely inhibited the binding of anti-F1-160 antibodies to nerve at a concentration of 80 ng/ml (30 microM). The two 18-residue peptides did not inhibit, even at 10 micrograms/ml. Thus, the epitope of F1-160 crossreactive with nervous tissue can be mapped to a 12-amino acid peptide. Some humans with T. cruzi infection make antibodies to F1-160 and to the 48X and 12X peptides. Control sera from uninfected persons did not react with these antigens. Anti-48X antibodies, immunoselected from human serum with 48X peptide, bind to human nerve axons. This demonstrates that some individuals infected with T. cruzi make antibodies to the F1-160 epitope crossreactive with nervous tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712477      PMCID: PMC52008          DOI: 10.1073/pnas.88.14.5993

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Trypanosome variant surface glycoprotein transfer to target membranes: a model for the pathogenesis of trypanosomiasis.

Authors:  M R Rifkin; F R Landsberger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  L3T4+ T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease.

Authors:  M Hontebeyrie-Joskowicz; G Said; G Milon; G Marchal; H Eisen
Journal:  Eur J Immunol       Date:  1987-07       Impact factor: 5.532

3.  Epitopes common to trypanosomes (T. cruzi, T. dionisii and T. vespertilionis (Schizotrypanum)): astrocytes and neurons.

Authors:  K Petry; P Voisin; T Baltz; J Labouesse
Journal:  J Neuroimmunol       Date:  1987-10       Impact factor: 3.478

4.  Chagasic cardiopathy. Demonstration of a serum gamma globulin factor which reacts with endocardium and vascular structures.

Authors:  P M Cossio; C Diez; A Szarfman; E Kreutzer; B Candiolo; R M Arana
Journal:  Circulation       Date:  1974-01       Impact factor: 29.690

5.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

6.  A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites.

Authors:  J N Wood; L Hudson; T M Jessell; M Yamamoto
Journal:  Nature       Date:  1982-03-04       Impact factor: 49.962

7.  Rapid analysis of amino acids using pre-column derivatization.

Authors:  B A Bidlingmeyer; S A Cohen; T L Tarvin
Journal:  J Chromatogr       Date:  1984-12-07

8.  Antigenic polymorphism of Trypanosoma cruzi: clonal analysis of trypomastigote surface antigens.

Authors:  F Plata; F Garcia Pons; H Eisen
Journal:  Eur J Immunol       Date:  1984-05       Impact factor: 5.532

9.  A monoclonal antibody with specificity for Trypanosoma cruzi, central and peripheral neurones and glia.

Authors:  D Snary; J E Flint; J N Wood; M T Scott; M D Chapman; J Dodd; T M Jessell; M A Miles
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

10.  Developmentally regulated, phospholipase C-mediated release of the major surface glycoprotein of amastigotes of Trypanosoma cruzi.

Authors:  N W Andrews; E S Robbins; V Ley; K S Hong; V Nussenzweig
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Infection, mimics, and autoimmune disease.

Authors:  N R Rose
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease.

Authors:  N Gironès; C I Rodríguez; E Carrasco-Marín; R F Hernáez; J L de Rego; M Fresno
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 3.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue.

Authors:  R L Tarleton; L Zhang; M O Downs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 5.  The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes.

Authors:  M J McConville; M A Ferguson
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

6.  The significantly reduced number of interstitial cells of Cajal in chagasic megacolon (CM) patients might contribute to the pathophysiology of CM.

Authors:  Sheila Jorge Adad; Gisele Barbosa E Silva; Alessandro Adad Jammal
Journal:  Virchows Arch       Date:  2012-08-16       Impact factor: 4.064

7.  HLA class I and II profiles of patients presenting with Chagas' disease.

Authors:  N H Deghaide; R O Dantas; E A Donadi
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

Review 8.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  Modulation of autoimmunity by treatment of an infectious disease.

Authors:  Kenneth V Hyland; Juan S Leon; Melvin D Daniels; Nick Giafis; LaKitta M Woods; Thomas J Bahk; Kegiang Wang; David M Engman
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

Review 10.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.